- Home
- Publications
- Publication Search
- Publication Details
Title
Development of novel vaccines against human cytomegalovirus
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume -, Issue -, Pages 1-11
Publisher
Informa UK Limited
Online
2019-04-25
DOI
10.1080/21645515.2019.1593729
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A randomized, phase 2 study of ASP0113, a DNA-based vaccine, for the prevention of CMV in CMV-seronegative kidney transplant recipients receiving a kidney from a CMV-seropositive donor
- (2018) Flavio Vincenti et al. AMERICAN JOURNAL OF TRANSPLANTATION
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions
- (2018) Cody S. Nelson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies
- (2018) Ilona Baraniak et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity
- (2018) Shinu John et al. VACCINE
- A fifty-year odyssey: Prospects for a cytomegalovirus vaccine in transplant and congenital infection
- (2018) Don J. Diamond et al. Expert Review of Vaccines
- Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice
- (2018) Flavia Chiuppesi et al. JOURNAL OF VIROLOGY
- Novel trimeric human cytomegalovirus glycoprotein B elicits a high-titer neutralizing antibody response
- (2018) Xinle Cui et al. VACCINE
- A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection
- (2018) Cody S. Nelson et al. npj Vaccines
- Perinatal Outcomes of Non-Primary Maternal Cytomegalovirus Infection: A 15-Year Experience
- (2017) Giuliana Simonazzi et al. FETAL DIAGNOSIS AND THERAPY
- Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
- (2017) Martin Alberer et al. LANCET
- Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
- (2017) Kapil Bahl et al. MOLECULAR THERAPY
- Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
- (2017) Francisco M. Marty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of homologous and heterologous prime-boost vaccine approaches using Modified Vaccinia Ankara and soluble protein to induce neutralizing antibodies by the human cytomegalovirus pentamer complex in mice
- (2017) Flavia Chiuppesi et al. PLoS One
- A synthetic human cytomegalovirus pp65-IE1 fusion antigen efficiently induces and expands virus specific T cells
- (2017) Ellen K. Link et al. VACCINE
- Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
- (2017) Anna Bootz et al. PLoS Pathogens
- Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination
- (2017) Fengsheng Li et al. npj Vaccines
- MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults
- (2016) Corinna La Rosa et al. BLOOD
- Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector
- (2016) Mark R. Schleiss et al. Clinical and Vaccine Immunology
- Safety of ASP0113, a cytomegalovirus DNA vaccine, in recipients undergoing allogeneic hematopoietic cell transplantation: an open-label phase 2 trial
- (2016) Takehiko Mori et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Comparative magnitude and kinetics of human cytomegalovirus-specific CD4+ and CD8+ T-cell responses in pregnant women with primary versus remote infection and in transmitting versus non-transmitting mothers: Its utility for dating primary infection in pre
- (2016) Chiara Fornara et al. JOURNAL OF MEDICAL VIROLOGY
- A replication-defective human cytomegalovirus vaccine for prevention of congenital infection
- (2016) D. Wang et al. Science Translational Medicine
- Replication-defective lymphocytic choriomeningitis virus vectors expressing guinea pig cytomegalovirus gB and pp65 homologs are protective against congenital guinea pig cytomegalovirus infection
- (2016) Rhonda D. Cardin et al. VACCINE
- Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial
- (2016) David I. Bernstein et al. VACCINE
- Mutual Interference between Cytomegalovirus and Reconstitution of Protective Immunity after Hematopoietic Cell Transplantation
- (2016) Matthias J. Reddehase Frontiers in Immunology
- Molecular mechanisms for enhanced DNA vaccine immunogenicity
- (2015) Lei Li et al. Expert Review of Vaccines
- Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast Infection
- (2015) Flavia Chiuppesi et al. JOURNAL OF VIROLOGY
- Maternal CD4+T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission
- (2015) Kristy M. Bialas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A cytomegalovirus DNA vaccine induces antibodies that block viral entry into fibroblasts and epithelial cells
- (2015) Michael A. McVoy et al. VACCINE
- Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortality
- (2015) Elizabeth C. Swanson et al. VACCINE
- Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody
- (2015) Sumana Chandramouli et al. Nature Communications
- Crystal Structure of the Human Cytomegalovirus Glycoprotein B
- (2015) Heidi G. Burke et al. PLoS Pathogens
- A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines
- (2014) Luis A Brito et al. MOLECULAR THERAPY
- A Randomized Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus
- (2014) Maria Grazia Revello et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies
- (2014) Anna Kabanova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Progress on pursuit of human cytomegalovirus vaccines for prevention of congenital infection and disease
- (2014) Tong-Ming Fu et al. VACCINE
- Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice
- (2014) Yingxia Wen et al. VACCINE
- Development of a novel, guinea pig-specific IFN-γ ELISPOT assay and characterization of guinea pig cytomegalovirus GP83-specific cellular immune responses following immunization with a modified vaccinia virus Ankara (MVA)-vectored GP83 vaccine
- (2014) Peter A. Gillis et al. VACCINE
- HCMV Infection of Human Trophoblast Progenitor Cells of the Placenta Is Neutralized by a Human Monoclonal Antibody to Glycoprotein B and Not by Antibodies to the Pentamer Complex
- (2014) Martin Zydek et al. Viruses-Basel
- A Neutralizing Anti-gH/gL Monoclonal Antibody Is Protective in the Guinea Pig Model of Congenital CMV Infection
- (2014) Marcy R. Auerbach et al. PLoS Pathogens
- Human Cytomegalovirus Vaccine Based on the Envelope gH/gL Pentamer Complex
- (2014) Felix Wussow et al. PLoS Pathogens
- Cytomegalovirus diseases after hematopoietic stem cell transplantation: A mini-review
- (2013) Ella J. Ariza-Heredia et al. CANCER LETTERS
- Enveloped Virus-Like Particle Expression of Human Cytomegalovirus Glycoprotein B Antigen Induces Antibodies with Potent and Broad Neutralizing Activity
- (2013) Marc Kirchmeier et al. Clinical and Vaccine Immunology
- Cytomegalovirus vaccine: phase II clinical trial results
- (2013) F. Rieder et al. CLINICAL MICROBIOLOGY AND INFECTION
- The “Silent” Global Burden of Congenital Cytomegalovirus
- (2013) Sheetal Manicklal et al. CLINICAL MICROBIOLOGY REVIEWS
- Management Strategies for Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients
- (2013) Raymund R. Razonable INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Fetal Human Cytomegalovirus Transmission Correlates with Delayed Maternal Antibodies to gH/gL/pUL128-130-131 Complex during Primary Infection
- (2013) Daniele Lilleri et al. PLoS One
- A series of 238 cytomegalovirus primary infections during pregnancy: description and outcome
- (2013) O. Picone et al. PRENATAL DIAGNOSIS
- Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine
- (2013) D. C. Freed et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Priorities for CMV vaccine development
- (2013) Philip R. Krause et al. VACCINE
- Recombinant MVA vaccines: dispelling the myths
- (2013) Matthew G. Cottingham et al. VACCINE
- Glycoprotein B (gB) vaccines adjuvanted with AS01 or AS02 protect female guinea pigs against cytomegalovirus (CMV) viremia and offspring mortality in a CMV-challenge model
- (2013) Mark R. Schleiss et al. VACCINE
- Antibodies Against Neutralization Epitopes of Human Cytomegalovirus gH/gL/pUL128-130-131 Complex and Virus Spreading May Correlate with Virus Control In Vivo
- (2012) Daniele Lilleri et al. JOURNAL OF CLINICAL IMMUNOLOGY
- A Vaccine Based on the Rhesus Cytomegalovirus UL128 Complex Induces Broadly Neutralizing Antibodies in Rhesus Macaques
- (2012) Felix Wussow et al. JOURNAL OF VIROLOGY
- Antibodies against the gH/gL/UL128/UL130/UL131 Complex Comprise the Majority of the Anti-Cytomegalovirus (Anti-CMV) Neutralizing Antibody Response in CMV Hyperimmune Globulin
- (2012) A. E. Fouts et al. JOURNAL OF VIROLOGY
- The Human Cytomegalovirus UL51 Protein Is Essential for Viral Genome Cleavage-Packaging and Interacts with the Terminase Subunits pUL56 and pUL89
- (2012) Eva Maria Borst et al. JOURNAL OF VIROLOGY
- A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2012) Mohamed A Kharfan-Dabaja et al. LANCET INFECTIOUS DISEASES
- Nonviral delivery of self-amplifying RNA vaccines
- (2012) A. J. Geall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies
- (2012) Rebecca J. Loomis et al. VACCINE
- HCMV gB shares structural and functional properties with gB proteins from other herpesviruses
- (2012) Sapna Sharma et al. VIROLOGY
- Cytomegalovirus in Solid Organ Transplantation: Epidemiology, Prevention, and Treatment
- (2012) Elena Beam et al. Current Infectious Disease Reports
- Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age
- (2011) Gisela Enders et al. JOURNAL OF CLINICAL VIROLOGY
- Glycoprotein B Vaccine Is Capable of Boosting Both Antibody and CD4 T-Cell Responses to Cytomegalovirus in Chronically Infected Women
- (2011) Steffanie Sabbaj et al. JOURNAL OF INFECTIOUS DISEASES
- Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial
- (2011) Paul D Griffiths et al. LANCET
- Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells
- (2011) Frances M. Saccoccio et al. VACCINE
- Quantitative analysis of neutralizing antibody response to human cytomegalovirus in natural infection
- (2011) Dai Wang et al. VACCINE
- Congenital Cytomegalovirus Mortality in the United States, 1990–2006
- (2011) Benjamin N. Bristow et al. PLoS Neglected Tropical Diseases
- B Cell Repertoire Analysis Identifies New Antigenic Domains on Glycoprotein B of Human Cytomegalovirus which Are Target of Neutralizing Antibodies
- (2011) Sonja Pötzsch et al. PLoS Pathogens
- Immune monitoring with iTAg MHC Tetramers for prediction of recurrent or persistent cytomegalovirus infection or disease in allogeneic hematopoietic stem cell transplant recipients: a prospective multicenter study
- (2010) J. W. Gratama et al. BLOOD
- Cytomegalovirus Seroprevalence in the United States: The National Health and Nutrition Examination Surveys, 1988–2004
- (2010) Sheri Lewis Bate et al. CLINICAL INFECTIOUS DISEASES
- Vaxfectin: a versatile adjuvant for plasmid DNA- and protein-based vaccines
- (2010) Sean M Sullivan et al. Expert Opinion on Drug Delivery
- Guinea pig cytomegalovirus: a model for the prevention and treatment of maternal–fetal cytomegalovirus transmission
- (2010) Mark R Schleiss et al. Future Virology
- Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity
- (2010) Lukas Flatz et al. NATURE MEDICINE
- Management of cytomegalovirus infection in solid organ transplantation
- (2010) Camille N. Kotton Nature Reviews Nephrology
- Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients
- (2009) W. Zhou et al. BLOOD
- Congenital cytomegalovirus: Public health action towards awareness, prevention, and treatment
- (2009) Gail J. Demmler-Harrison JOURNAL OF CLINICAL VIROLOGY
- Development and evidence for efficacy of CMV glycoprotein B vaccine with MF59 adjuvant
- (2009) Robert F. Pass JOURNAL OF CLINICAL VIROLOGY
- Isolation of Human Monoclonal Antibodies That Potently Neutralize Human Cytomegalovirus Infection by Targeting Different Epitopes on the gH/gL/UL128-131A Complex
- (2009) A. Macagno et al. JOURNAL OF VIROLOGY
- Conditional and reversible disruption of essential herpesvirus proteins
- (2009) Mandy Glaß et al. NATURE METHODS
- Vaccine Prevention of Maternal Cytomegalovirus Infection
- (2009) Robert F. Pass et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure of a trimeric variant of the Epstein–Barr virus glycoprotein B
- (2009) Marija Backovic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers
- (2009) David I. Bernstein et al. VACCINE
- A CMV DNA vaccine primes for memory immune responses to live-attenuated CMV (Towne strain)
- (2009) Mark A. Jacobson et al. VACCINE
- Entry of herpesviruses into mammalian cells
- (2008) E. E. Heldwein et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Structures and Mechanisms of Viral Membrane Fusion Proteins: Multiple Variations on a Common Theme
- (2008) Judith M. White et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Cytomegalovirus seroprevalence and childhood sources of infection: A population-based study among pre-adolescents in the United States
- (2008) Stephanie A.S. Staras et al. JOURNAL OF CLINICAL VIROLOGY
- Safety and Immunogenicity of a Bivalent Cytomegalovirus DNA Vaccine in Healthy Adult Subjects
- (2008) Mary K. Wloch et al. JOURNAL OF INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search